The Goldman Sachs Group Inc (FRA:GOS)
€ 576.4 -4.3 (-0.74%) Market Cap: 180.89 Bil Enterprise Value: 379.26 Bil PE Ratio: 17.86 PB Ratio: 1.77 GF Score: 76/100

Dassault Systemes SE Webcast Hosted By Goldman Sachs Transcript

Jun 12, 2020 / NTS GMT
Release Date Price: €178.68 (+2.40%)
Mohammed Essaji Moawalla
Goldman Sachs Group, Inc., Research Division - Equity Analyst

Good afternoon, everybody in Europe, and good morning, everyone, in North America. We are delighted to welcome you to a webcast that we have organized with Dassault Systemes. My name is Mohammed Moawalla, and I cover the European software sector here at GS in Europe. And we are delighted to do a drilldown into Dassault's Life Sciences business, which is an exciting new opportunity for the company.

On the call with us today from the company is Pascal Daloz, the Chief Operating Officer and Chief Financial Officer of Dassault Systemes. Joining him is Tarek Sherif, who is the Co-Founder and CEO of Medidata. And we also have Rouven Bergmann, who is the Chief Operating Officer and Chief Financial Officer of Medidata.

So before we begin, and we will kick off with a few questions. And if you would like to ask any questions, feel free to send them to the webcast, but you can also e-mail them to me at [email protected]. And before we start, I just need to read out some disclosures. We are required to make

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot